Curaleaf (OTCMKTS:CURLF – Get Free Report) was downgraded by equities research analysts at Atb Cap Markets from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday,Zacks.com reports.
Several other brokerages have also recently issued reports on CURLF. Canaccord Genuity Group upgraded shares of Curaleaf to a “strong-buy” rating in a research report on Thursday, October 9th. Cormark raised Curaleaf from a “hold” rating to a “moderate buy” rating in a research report on Friday, August 8th. Two equities research analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy”.
Read Our Latest Stock Analysis on CURLF
Curaleaf Stock Performance
Curaleaf (OTCMKTS:CURLF – Get Free Report) last issued its quarterly earnings data on Wednesday, November 5th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 19.50% and a negative return on equity of 15.54%. As a group, research analysts expect that Curaleaf will post -0.25 earnings per share for the current year.
About Curaleaf
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Read More
- Five stocks we like better than Curaleaf
- Want to Profit on the Downtrend? Downtrends, Explained.
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- Why Invest in 5G? How to Invest in 5G Stocks
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
- What is the S&P/TSX Index?
- CrowdStrike Partners With CoreWeave But Investors Sell the News
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.
